| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.039 | 0.5 |